TLL-018 (a JAK1/TYK2 agent) vs. Tofacitinib in RA
Dr. Peter Nash reporting on abstract LB0001 from EULAR 2023 in Milan, Italy.
Watch video →Dr. Peter Nash reporting on abstract LB0001 from EULAR 2023 in Milan, Italy.
Watch video →Join Drs. Jack Cush, David Liew and Bella Mehta as they recap data presented on Day 4 at EULAR 2023 in Milan, Italy.
Watch video →Dr. Peter Nash reports on abstract OP0139 EULAR 2023 in Milan, Italy.
Watch video →Drs. Antoni Chan, Jack Cush and Yuz Yusof report from EULAR 2023 in Milan, Italy.
Watch video →Dr. Eric Ruderman discusses abstract OP0063 presented at EULAR 2023 in Milan, Italy.
Watch video →Dr. Peter Nash reporting from EULAR 2023 in Milan, Italy.
Watch video →Dr. Jack Cush, executive editor of RheumNow, reporting on abstract OP0219 from EULAR 2023 in Milan, Italy.
Watch video →Dr. Jack Cush discusses abstract OP0272 at EULAR 2023 in Milan, Italy.
Watch video →Dr. Jack Cush, executive editor, RheumNow, discussing OP0130 from EULAR 2023 in Milan, Italy.
Watch video →Dr. Eric Ruderman discusses abstracts OP0068 and OP0299 at EULAR 2023 in Milan, Italy.
Watch video →AOSD: Young vs. Elderly Onset AOSDis an autoinflammatory condition characterized by fevers, arthritis, and rash. It is considered an orphan disease because of its low prevalence - it is reported anywhere between 16 to 40 per ten million. https://t.co/bB2mpul3j7 https://t.co/ic6mY04ddF
By downloading this material, I acknowledge that it may be used only for personal use and personal education and that I will accredit RheumNow.com as the source and owner of this material. Commercial use or mass reproduction of this material without permission from RheumNow (info@rheumnow.com) is prohibited.